Relación del microbiota intestinal en patologías cutáneas
Relationship of the intestinal microbiota in skin pathologiesBarra lateral del artículo
Contenido principal del artículo
El microbiota intestinal se encuentra constituida por más un millón de microorganismos entre los cuales las bacterias son de mayor prevalencia. Esta microbiota depende directamente de la localización exacta a lo largo del tubo digestivo, siendo la porción del colon la que alberga la mayor cantidad del microorganismo de la flora. El microbiota de la piel guarda relación directa con el microbiota del intestino por los diversos mecanismos existentes en la formación de la misma. El objetivo del presente estudio fue analizar el uso de probióticos y prebióticos en tratamiento de patología cutáneas y la relación entre la microbiota intestinal y enfermedades de la piel. Se realizó una revisión bibliográfica narrativa de la literatura científica de la relación del microbiota intestinal en patologías cutáneas. Se concluyó que el uso de probióticos y prebióticos juegan un papel importante en enfermedad cutáneas es especial de tipo inflamatoria.
The intestinal microbiota is constituted by more than one million microorganisms among which bacteria are the most prevalent. This microbiota is directly dependent on the exact location along the digestive tract, with the colon portion harboring the largest amount of the microorganism flora. The skin microbiota is directly related to the gut microbiota by the various mechanisms involved in its formation. The aim of the present study was to analyze the use of probiotics and prebiotics in the treatment of skin pathology and the relationship between the intestinal microbiota and skin diseases. A narrative bibliographic review of the scientific literature on the relationship between the intestinal microbiota and skin pathologies was carried out. It was concluded that the use of probiotics and prebiotics play an important role in skin diseases, especially inflammatory ones.
Descargas
Detalles del artículo
Kataoka K. The intestinal microbiota and its role in human health and disease. J Med Invest [Internet]. 2016 Apr 1 [cited 2022 Sep 21];63(1–2):27–37. Available from: https://pubmed.ncbi.nlm.nih.gov/27040049/
Rasmussen HE, Hamaker BR. Prebiotics and Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2017 Dec 1;46(4):783–95. DOI:https://doi.org/10.1016/j.gtc.2017.08.004
Becker C, Neurath MF, Wirtz S. The intestinal microbiota in inflammatory bowel disease. ILAR J. 2015 Aug 31;56(2):192–204. https://doi.org/10.1093/ilar/ilv030
Healey GR, Celiberto LS, Lee SM, Jacobson K. Fiber and prebiotic interventions in pediatric inflammatory bowel disease: What role does the gut microbiome play? Nutrients. 2020 Oct 1;12(10):1–23. https://doi.org/10.3390/nu12103204
Margolles A. Factores implicados en el establecimiento y desarrollo de la microbiota | El Probiótico [Internet]. 2020 [cited 2022 Sep 21]. p. 389–402. Available from: https://www.elprobiotico.com/factores-establecimiento-desarrollo-microbiota/
Leblanc JF, Segal JP, de Campos Braz LM, Hart AL. The microbiome as a therapy in pouchitis and ulcerative colitis. Nutrients. 2021 Jun 1;13(6). https://doi.org/10.3390/nu13061780
Potel C, Ortega A, Martinez-Lamas L, Bautist V, Regueiro B, Oteo J. Interspecies Transmission of the blaOXA-48 Gene from a Klebsiella pneumoniae High-Risk Clone of Sequence Type 147 to Different Escherichia coli Clones in the Gut Microbiota. Antimicrob Agents Chemother [Internet]. 2017 Jan 1 [cited 2022 Sep 21];62(1). Available from: https://pubmed.ncbi.nlm.nih.gov/29133556/
La OMS alerta de que el desarrollo de nuevos antibióticos está “estancado” | Noticias ONU [Internet]. [cited 2022 Sep 21]. Available from: https://news.un.org/es/story/2022/06/1510742
Belkaid Y, Hand TW. Role of the Microbiota in Immunity and inflammation. Cell [Internet]. 2014 Mar 3 [cited 2022 Sep 21];157(1):121. Available from: /pmc/articles/PMC4056765/
Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol [Internet]. 2019 Oct 1 [cited 2022 Sep 22];16(10):605–16. Available from: https://pubmed.ncbi.nlm.nih.gov/31296969/
Yu Y, Dunaway S, Champer J, Kim J, Alikhan A. Changing our microbiome: probiotics in dermatology. Br J Dermatol [Internet]. 2020 Jan 1 [cited 2022 Sep 22];182(1):39–46. Available from: https://pubmed.ncbi.nlm.nih.gov/31049923/
Baptista IPN da C, Accioly E, Padilha P de C. Efecto del uso de los probióticos en el tratamiento de niños con dermatitis atópica: revisión bibliográfica. Nutr Hosp [Internet]. 2013 [cited 2022 Sep 22];28(1):16–26. Available from: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112013000100003&lng=es&nrm=iso&tlng=en
Alarcón P, González M, Castro É. Rol de la microbiota gastrointestinal en la regulación de la respuesta inmune. Rev Med Chil [Internet]. 2016 Jul 1 [cited 2022 Sep 22];144(7):910–6. Available from: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000700013&lng=es&nrm=iso&tlng=pt
Álvarez J, Fernández Real JM, Guarner F, Gueimonde M, Rodríguez JM, Saenz de Pipaon M, et al. Microbiota intestinal y salud. Gastroenterol Hepatol. 2021 Aug 1;44(7):519–35. https://doi.org/10.1016/j.gastrohep.2021.01.009
Gracia-Cazaña T, González S, Parrado C, Juarranz, Gilaberte Y. La influencia del exposoma en el cáncer de piel. Actas Dermosifiliogr. 2020 Jul 1;111(6):460–70. https://doi.org/10.1016/j.ad.2020.04.008
Icaza-Chávez ME. Microbiota intestinal en la salud y la enfermedad. Rev Gastroenterol México [Internet]. 2013 Oct 1 [cited 2022 Sep 21];78(4):240–8. Available from: http://www.revistagastroenterologiamexico.org//es-microbiota-intestinal-salud-enfermedad-articulo-S0375090613001468
Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, et al. The NIH Human Microbiome Project. Genome Res [Internet]. 2009 Dec [cited 2022 Sep 21];19(12):2317. Available from: /pmc/articles/PMC2792171/
Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science (80- ) [Internet]. 2016 Apr 29 [cited 2022 Sep 21];352(6285):539–44. Available from: https://www.science.org/doi/10.1126/science.aad9378
Linares DM, Ross P, Stanton C. Beneficial Microbes: The pharmacy in the gut. https://doi.org/101080/2165597920151126015 [Internet]. 2016 Jan 2 [cited 2022 Sep 21];7(1):11–20. Available from: https://www.tandfonline.com/doi/abs/10.1080/21655979.2015.1126015
Sebastián-Domingo J-J, Sánchez-Sánchez C, Sebastián-Domingo J-J, Sánchez-Sánchez C. De la flora intestinal al microbioma. Rev Española Enfermedades Dig [Internet]. 2018 [cited 2022 Sep 21];110(1):51–6. Available from: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082018000100009&lng=es&nrm=iso&tlng=es
Zelante T, Iannitti RG, Cunha C, DeLuca A, Giovannini G, Pieraccini G, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity [Internet]. 2013 Aug 22 [cited 2022 Sep 21];39(2):372–85. Available from: https://pubmed.ncbi.nlm.nih.gov/23973224/
O’Neill CA, Monteleone G, McLaughlin JT, Paus R. The gut-skin axis in health and disease: A paradigm with therapeutic implications. Bioessays [Internet]. 2016 Nov 1 [cited 2022 Sep 21];38(11):1167–76. Available from: https://pubmed.ncbi.nlm.nih.gov/27554239/
Belkaid Y, Segre JA. Dialogue between skin microbiota and immunity. Science [Internet]. 2014 Nov 21 [cited 2022 Sep 21];346(6212):954–9. Available from: https://pubmed.ncbi.nlm.nih.gov/25414304/
Schwarz A, Bruhs A, Schwarz T. The Short-Chain Fatty Acid Sodium Butyrate Functions as a Regulator of the Skin Immune System. J Invest Dermatol [Internet]. 2017 Apr 1 [cited 2022 Sep 21];137(4):855–64. Available from: https://pubmed.ncbi.nlm.nih.gov/27887954/
Shu M, Wang Y, Yu J, Kuo S, Coda A, Jiang Y, et al. Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus. PLoS One [Internet]. 2013 Feb 6 [cited 2022 Sep 21];8(2). Available from: https://pubmed.ncbi.nlm.nih.gov/23405142/
Benyacoub J, Bosco N, Blanchard C, Demont A, Philippe D, Castiel-Higounenc I, et al. Immune modulation property of Lactobacillus paracasei NCC2461 (ST11) strain and impact on skin defences. Benef Microbes [Internet]. 2014 [cited 2022 Sep 21];5(2):129–36. Available from: https://pubmed.ncbi.nlm.nih.gov/24322880/
Baba H, Masuyama A, Yoshimura C, Aoyama Y, Takano T, Ohki K. Oral Intake of Lactobacillus helveticus-Fermented Milk Whey Decreased Transepidermal Water Loss and Prevented the Onset of Sodium Dodecylsulfate-Induced Dermatitis in Mice. Biosci Biotechnol Biochem [Internet]. 2010 Jan 23 [cited 2022 Sep 21];74(1):18–23. Available from: https://academic.oup.com/bbb/article/74/1/18/5949701
Gueniche A, Benyacoub J, Philippe D, Bastien P, Kusy N, Breton L, et al. Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. Eur J Dermatol [Internet]. 2010 Nov [cited 2022 Sep 21];20(6):731–7. Available from: https://pubmed.ncbi.nlm.nih.gov/20965806/
Peguet-Navarro J, Dezutter-Dambuyant C, Buetler T, Leclaire J, Smola H, Blum S, et al. Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, randomized, placebo controlled clinical trial. Eur J Dermatology. 2008 Sep;18(5):504–11. DOI: 10.1684/ejd.2008.0496
Suárez JE. [Autochthonous microbiota, probiotics and prebiotics]. Nutr Hosp [Internet]. 2015 [cited 2022 Sep 21];31 Suppl 1:3–9. Available from: https://pubmed.ncbi.nlm.nih.gov/25659048/
Al-Ghazzewi FH, Tester RF. Impact of prebiotics and probiotics on skin health. Benef Microbes. 2014;5(2):99–107. https://doi.org/10.3920/BM2013.0040